Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Rey

Showing results (241-250 of 269) with videos related to

Pageof 27
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 16, 2007
Incidence of and risk factors for severe liver toxicity in HIV-infected patients on anti-tuberculosis treatmentE Pukenyte, F X Lescure, D Rey, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 29, 1999
Isolated renal Aspergillus abscess in an AIDS patient with a normal CD4+ cell count on highly active antiretroviral therapyD Rey, E de Mautort, C Saussine, et al.
European Journal of Dermatology : EJD|December 17, 1998
Porphyria cutanea tarda associated with human immunodeficiency virus infectionC Drobacheff, C Derancourt, H Van Landuyt, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 21, 2001
Efavirenz as a substitute for protease inhibitors in HIV-1-infected patients with undetectable plasma viral load on HAART: a median follow-up of 64 weeksD Rey, M P Schmitt, M Partisani, et al.
Epidemiology and Infection|January 15, 2011
A decision tree to help determine the best timing and antiretroviral strategy in HIV-infected patientsL Piroth, I Fournel, S Mahy, et al.
Molecular Biology Reports|November 27, 2010
HLA in Jaidukama: an Amerindian secluded Colombian population with new haplotypes and Asian and Pacific-shared allelesJ Martinez-Laso, F Montoya, C Areces, et al.
Vaccine|January 29, 2000
Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral loadD Rey, V Krantz, M Partisani, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 17, 2016
Predictive value of hypoxia in advanced head and neck cancer after treatment with hyperfractionated radio-chemotherapy and hypoxia modificationB Clavo, F Robaina, D Fiuza, et al.
Arquivos De Neuro-Psiquiatria|September 1, 1990
[Diagnosis and treatment of myasthenia gravis: study of an inpatient population]R D Rey, O P Sanz, J M Fernández, et al.
Journal of Viral Hepatitis|October 7, 2017
Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus-co-infected patients (ANRS CO13-HEPAVIH)S Nordmann, A Vilotitch, P Roux, et al.
Pageof 27

Showing results (241-250 of 269) with videos related to

Sort By:
Pageof 27
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 16, 2007
Incidence of and risk factors for severe liver toxicity in HIV-infected patients on anti-tuberculosis treatmentE Pukenyte, F X Lescure, D Rey, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 29, 1999
Isolated renal Aspergillus abscess in an AIDS patient with a normal CD4+ cell count on highly active antiretroviral therapyD Rey, E de Mautort, C Saussine, et al.
European Journal of Dermatology : EJD|December 17, 1998
Porphyria cutanea tarda associated with human immunodeficiency virus infectionC Drobacheff, C Derancourt, H Van Landuyt, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 21, 2001
Efavirenz as a substitute for protease inhibitors in HIV-1-infected patients with undetectable plasma viral load on HAART: a median follow-up of 64 weeksD Rey, M P Schmitt, M Partisani, et al.
Epidemiology and Infection|January 15, 2011
A decision tree to help determine the best timing and antiretroviral strategy in HIV-infected patientsL Piroth, I Fournel, S Mahy, et al.
Molecular Biology Reports|November 27, 2010
HLA in Jaidukama: an Amerindian secluded Colombian population with new haplotypes and Asian and Pacific-shared allelesJ Martinez-Laso, F Montoya, C Areces, et al.
Vaccine|January 29, 2000
Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral loadD Rey, V Krantz, M Partisani, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 17, 2016
Predictive value of hypoxia in advanced head and neck cancer after treatment with hyperfractionated radio-chemotherapy and hypoxia modificationB Clavo, F Robaina, D Fiuza, et al.
Arquivos De Neuro-Psiquiatria|September 1, 1990
[Diagnosis and treatment of myasthenia gravis: study of an inpatient population]R D Rey, O P Sanz, J M Fernández, et al.
Journal of Viral Hepatitis|October 7, 2017
Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus-co-infected patients (ANRS CO13-HEPAVIH)S Nordmann, A Vilotitch, P Roux, et al.
Pageof 27